Comparison of two oral iron preparations for treatment of iron deficiency anemia in childre

Not Applicable

Conditions: Health Condition 1: D509- Iron deficiency anemia, unspecified

Registration Number: CTRI/2024/05/066760

Lead Sponsor: Intra-Mural Research Grant by University College of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: ot Yet Recruiting

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

Iron deficiency anemia will be defined as hemoglobin less than 11 g/dL and categorized as per WHO definition with peripheral blood smear suggestive of microcytic hypochromic picture AND low mean corpuscular volume and low serum ferritin

below 12 mcg/L in the absence of infection and below 30 mcg/L in the presence of infection

Exclusion Criteria

Children with anemia due to dimorphic or megalobastic blood picture in peripheral smear or apparent non-nutritional etiology of anemia (obvious bleeding or chronic hemolytic anemia or malignancies) or known or suspected chronic systemic disease or those who have received iron preparations during last 2 weeks or those who received blood/packed cell transfusion within last 3 months will be excluded

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Proportion of non-anemic children after 12 weeks of therapyTimepoint: 12 weeks

Secondary Outcome Measures

Name	Time	Method
1.Proportion of participants compliant to oral iron therapy in the two groups <br/ ><br>2.Side effects experienced among the two groups. <br/ ><br>3.Proportion of children having appetite recovery using 16-item Early Childhood Appetite and Satiety Tool (ECAST) ? at 1, 2 and 4 weeks. <br/ ><br>4.Hb at baseline, 2, 8 and 12 weeks of therapy. <br/ ><br>5.Serum ferritin level at baseline and week 12. <br/ ><br>Timepoint: 1, 2, 4, 8, 12 weeks